Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Piot

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Stem Cell Research & Therapy|January 16, 2014
Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trialGuillaume Lamirault, Sophie Susen, Virginie Forest, et al.
Journal of the American College of Cardiology|March 20, 2010
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarctionNathan Mewton, Pierre Croisille, Gerald Gahide, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 31, 2023
A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trialGiuseppe Tarantini, Peter Cornelius Smits, Thibault Lhermusier, et al.
Stem Cell Research & Therapy|April 24, 2022
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injuryCharlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, et al.
Stem Cell Research & Therapy|July 26, 2022
Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injuryCharlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, et al.
American Heart Journal|January 22, 2024
Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trialNidal Jammoul, Valentin Dupasquier, Mariama Akodad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2015
Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trialAlain Manrique, Patricia Lemarchand, Béatrice Delasalle, et al.
Basic Research in Cardiology|September 12, 2013
Postconditioning attenuates no-reflow in STEMI patientsNathan Mewton, Hélène Thibault, François Roubille, et al.
The American Journal of Cardiology|May 12, 2019
Hemodynamic Performances and Clinical Outcomes in Patients Undergoing Valve-in-Valve Versus Native Transcatheter Aortic Valve ImplantationMariama Akodad, Alexandra Meilhac, Thierry Lefèvre, et al.
Journal of the American College of Cardiology|June 9, 2012
Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarctionFranck Thuny, Olivier Lairez, François Roubille, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Stem Cell Research & Therapy|January 16, 2014
Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trialGuillaume Lamirault, Sophie Susen, Virginie Forest, et al.
Journal of the American College of Cardiology|March 20, 2010
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarctionNathan Mewton, Pierre Croisille, Gerald Gahide, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 31, 2023
A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trialGiuseppe Tarantini, Peter Cornelius Smits, Thibault Lhermusier, et al.
Stem Cell Research & Therapy|April 24, 2022
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injuryCharlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, et al.
Stem Cell Research & Therapy|July 26, 2022
Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injuryCharlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, et al.
American Heart Journal|January 22, 2024
Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trialNidal Jammoul, Valentin Dupasquier, Mariama Akodad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2015
Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trialAlain Manrique, Patricia Lemarchand, Béatrice Delasalle, et al.
Basic Research in Cardiology|September 12, 2013
Postconditioning attenuates no-reflow in STEMI patientsNathan Mewton, Hélène Thibault, François Roubille, et al.
The American Journal of Cardiology|May 12, 2019
Hemodynamic Performances and Clinical Outcomes in Patients Undergoing Valve-in-Valve Versus Native Transcatheter Aortic Valve ImplantationMariama Akodad, Alexandra Meilhac, Thierry Lefèvre, et al.
Journal of the American College of Cardiology|June 9, 2012
Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarctionFranck Thuny, Olivier Lairez, François Roubille, et al.
Pageof 8